Código QR (código de barras bidimensional)

Ion channel inhibition with amiodarone or verapamil in symptomatic hospitalized nonintensive-care COVID-19 patients: The ReCOVery-SIRIO randomized trial

BACKGROUND: Ion channel inhibition may offer protection against coronavirus disease 2019 (COVID-19). Inflammation and reduced platelet count occur during COVID-19 but precise quantification of risk thresholds is unclear. The Recov ery-SIRIO study aimed to assess clinical effects of amiodarone and ve...

Fuld beskrivelse

Na minha lista:
Principais autores: Eliano P. Navarese, Przemysław Podhajski, Felicita Andreotti, Giuseppe La Torre, Robert Gajda, Adrian Radziwanowski, Małgorzata Nowicka, Paweł Bukowski, Jacek Gajda, Maciej Omyła, Piotr Lackowski, Maciej Piasecki, Małgorzata Jasiewicz, Paweł Szymański, Łukasz Pietrzykowski, Piotr Michalski, Aldona Kubica, Iwona Urbanowicz, Nicola Orsini, Max Conte, Jarosław Pinkas, Marc A. Brouwer, Jacek Kubica
Format: Artigo
Sprog:Inglês
Udgivet: Via Medica 2022-09-01
Serier:Cardiology Journal
Fag:
amiodarone
verapamil
COVID-19
ion-channel inhibition
randomized trial
Online adgang:https://journals.viamedica.pl/cardiology_journal/article/view/88627
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker